Skip to main content
Log in

Totale Beckenexenteration

Total pelvic exenteration

  • Leitthema
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Die totale Beckenexenteration hat sich in den letzten Jahrzehnten zu einem etablierten und sicheren Verfahren zur Resektion lokal fortgeschrittener Beckenmalignome mit 5-Jahres-Überlebensraten von bis zu 66% je nach Tumorentität und mit einer zufriedenstellenden postoperativen Lebensqualität entwickelt. Eine Beckenwandinfiltration oder resektable Fernmetastasen müssen heute keine Kontraindikation für eine Beckenexenteration darstellen; darüber hinaus kann die Beckenexenteration auch zur Palliation indiziert sein. Auch beim Rektumkarzinomrezidiv können gute Ergebnisse erreicht werden. Ein multidisziplinärer Ansatz in Diagnostik und Therapie ist bei diesen Eingriffen von großer Bedeutung, daher sollten sie in dafür spezialisierten Zentren durchgeführt werden.

Abstract

Over the last decades total pelvic exenteration (TPE) has evolved into an established and safe surgical technique for locally advanced pelvic malignancies. Depending on the type of cancer 5 year overall survival rates of up to 66% and a satisfactory postsurgical quality of life have been reported. Currently infiltration of the pelvic side wall and resectable metasases are not necessarily a contraindication to a curative approach; furthermore, TPE can also be useful in palliative surgery. In locally recurrent rectal cancer TPE is the treatment of choice if the tumor is deemed resectable. A multidisciplinary diagnostic and therapeutic approach is of utmost importance, hence patients should be treated in specialized centers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183

    Article  CAS  PubMed  Google Scholar 

  2. De Chaisemartin C, Penna C, Goere D et al (2009) Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis 11:60–66

    Article  Google Scholar 

  3. Ferenschild FT, Vermaas M, Verhoef C et al (2009) Total pelvic exenteration for primary and recurrent malignancies. World J Surg 33:1502–1508

    Article  CAS  PubMed  Google Scholar 

  4. Forner DM, Meyer A, Lampe B (2010) Preoperative assessment of complete tumour resection by magnetic resonance imaging in patients undergoing pelvic exenteration. Eur J Obstet Gynecol Reprod Biol 148:182–185

    Article  PubMed  Google Scholar 

  5. Guren MG, Wiig JN, Dueland S et al (2001) Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. Eur J Surg Oncol 27:645–651

    Article  CAS  PubMed  Google Scholar 

  6. Hockel M (2006) Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol 32:859–865

    Article  CAS  PubMed  Google Scholar 

  7. Hockel M, Dornhofer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7:837–847

    Article  PubMed  Google Scholar 

  8. Husain A, Akhurst T, Larson S et al (2007) A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177–180

    Article  CAS  PubMed  Google Scholar 

  9. Jurado M, Alcazar JL, Martinez-Monge R (2010) Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience. Gynecol Oncol 116:38–43

    Article  PubMed  Google Scholar 

  10. Kohler C, Tozzi R, Possover M et al (2002) Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol 86:311–315

    Article  PubMed  Google Scholar 

  11. Rahbari NN (2010) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision (TME): Is there still a chance for cure? Ann Surg (in press)

  12. Said HK, Bevers M, Butler CE (2007) Reconstruction of the pelvic floor and perineum with human acellular dermal matrix and thigh flaps following pelvic exenteration. Gynecol Oncol 107:578–582

    Article  PubMed  Google Scholar 

  13. Torricelli P (2007) Rectal cancer staging. Surg Oncol 16(Suppl 1):49–50

    Article  Google Scholar 

  14. Turns D (2001) Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 76:224–236

    Article  CAS  PubMed  Google Scholar 

  15. Ungar L, Palfalvi L (2006) Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients. Int J Gynecol Cancer 16:364–368

    Article  CAS  PubMed  Google Scholar 

  16. Vermaas M, Ferenschild FT, Verhoef C et al (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33:452–458

    Article  CAS  PubMed  Google Scholar 

  17. Wright FC, Crooks D, Fitch M et al (2006) Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 93:92–99

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Weitz MSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heger, U., Koch, M., Büchler, M. et al. Totale Beckenexenteration. Chirurg 81, 897–901 (2010). https://doi.org/10.1007/s00104-010-1945-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-010-1945-z

Schlüsselwörter

Keywords

Navigation